Article Versions Notes

Mishchenko M, Shtrygol’ S, Lozynskyi A, Khomyak S, Novikov V, Karpenko O, Holota S, Lesyk R. Evaluation of Anticonvulsant Activity of Dual COX-2/5-LOX Inhibitor Darbufelon and Its Novel Analogues. Scientia Pharmaceutica. 2021; 89(2):22. https://doi.org/10.3390/scipharm89020022

Mishchenko, Mariia, Sergiy Shtrygol’, Andrii Lozynskyi, Semen Khomyak, Volodymyr Novikov, Olexandr Karpenko, Serhii Holota, and Roman Lesyk. 2021. "Evaluation of Anticonvulsant Activity of Dual COX-2/5-LOX Inhibitor Darbufelon and Its Novel Analogues" Scientia Pharmaceutica 89, no. 2: 22. https://doi.org/10.3390/scipharm89020022

Mishchenko, M., Shtrygol’, S., Lozynskyi, A., Khomyak, S., Novikov, V., Karpenko, O., Holota, S., & Lesyk, R. (2021). Evaluation of Anticonvulsant Activity of Dual COX-2/5-LOX Inhibitor Darbufelon and Its Novel Analogues. Scientia Pharmaceutica, 89(2), 22. https://doi.org/10.3390/scipharm89020022